December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Adjuvant Therapy for Invasive Sino-orbital Fungal Infection
Author Affiliations & Notes
  • RE Turbin
    UMDNJ-NJMS Newark NJ
  • SA Khoobiar
    Newark NJ
  • P Langer
    UMDNJ-NJMS Newark NJ
  • K Amesur
    Ophthalmology NYU New York NY
  • L Frohman
    UMDNJ-NJMS Newark NJ
  • F Warren
    Ophthalmology NYU New York NY
  • S Baredes
    UMDNJ-NJMS Newark NJ
  • JS Kennerdell
    Ophthalmology AGH Pittsburgh PA
  • Footnotes
    Commercial Relationships   R.E. Turbin, None; S.A. Khoobiar, None; P. Langer, None; K. Amesur, None; L. Frohman, None; F. Warren, None; S. Baredes, None; J.S. Kennerdell, None. Grant Identification: Support: RPB, Inc.; Lions Eye Research; Eye Institute of New Jersey
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2637. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      RE Turbin, SA Khoobiar, P Langer, K Amesur, L Frohman, F Warren, S Baredes, JS Kennerdell; Adjuvant Therapy for Invasive Sino-orbital Fungal Infection . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2637.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:To report the authors experience in the management of invasive sino-orbital fungal infection treated with retrobulbar injection and surgical or post-operative irrigation of amphotericin B (AmphB) as an adjuvant to systemic antifungal therapy, and limited, conservative, biopsy or debridement procedures. Methods:Retrospective chart review of a consecutive case series. Data concerning comorbid conditions, vision, motility and orbital examination, radiographic findings, and clinical outcome are provided. Fungal species, treatment data, and surgical procedures are described. Results:Five patients suffered biopsy proven invasive fungal sino-orbital infection (2 rhizopus, 1 mucor, 1 aspergillosis, 1 rhodotorula mucilaginosa/alternaria /hormographiella) related to comorbid conditions (leukemia, renal transplant, diabetic keto-acidosis, corticosteroid therapy, retained intraorbital foreign body) Adjuvant therapy supplementing systemic antifungal therapy included retrobulbar/peribulbar injection ( 3-5 cc of 2mg/cc AmphB) and sino-orbital irrigation (50-500cc of 0.2- 0.5mmg/cc AmphB) Two patients who presented prior to onset of complete blindness (counting fingers, and 20/40 soon worsening to no light perception) in the affected eye maintained useful visual function at latest examination (20/80 and 20/25, respectively) Five patients showed improvement in orbital and motility examination. No patient required orbital exenteration, or extensive disfiguring facial debridement. Conclusion:Adjuvant orbital therapy with Amphotericin B is safe and appears effective in controlling orbital fungal infection. In selected cases, it may prevent disfiguring surgery, may be associated with improvement in ophthalmoplegia, and may preserve visual function when begun prior to onset of complete blindness.

Keywords: 414 fungal disease • 501 orbit • 436 injection 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.